Stock Analysis on Net
Stock Analysis on Net

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX)

$24.99

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Paying user area

Try for free

Vertex Pharmaceuticals Inc. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Vertex Pharmaceuticals Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in thousands

Microsoft Excel
Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Accounts payable
Accrued expenses
Other current liabilities
Current liabilities
Long-term operating lease liabilities
Other long-term liabilities
Long-term liabilities
Total liabilities
Preferred stock, $0.01 par value; none issued
Common stock, $0.01 par value
Additional paid-in capital
Accumulated other comprehensive income (loss)
Retained earnings (accumulated deficit)
Shareholders’ equity
Total liabilities and shareholders’ equity

Based on: 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).

Accounts Payable
The accounts payable balance exhibited fluctuations over the periods, starting at approximately 100.7 million and experiencing a significant increase in the fourth quarter of 2020 reaching 155.1 million. Post-2020, the balance generally trended upward, peaking around 445.0 million in the third quarter of 2025 before slightly receding in the final observed quarter. This presents a pattern of increasing short-term obligations to suppliers and creditors.
Accrued Expenses
Accrued expenses showed a rising trend overall, with values starting at 1.26 billion and escalating to over 3.6 billion by mid-2025. Despite some periodic dips, particularly in the last quarters of 2024 and early 2025, the general direction indicates an increasing amount of expenses incurred but not yet paid, demonstrating growing operating costs or deferred payments.
Other Current Liabilities
This category was relatively volatile, increasing sharply in late 2020 to over 317.4 million, dropping and surging again thereafter. The highest levels were observed in late 2023 and early 2024, exceeding over 600 million at one point, before showing moderate fluctuations but generally remaining elevated, suggesting variability in short-term obligations not classified elsewhere.
Current Liabilities
Current liabilities consistently increased over time, rising from approximately 1.54 billion to nearly 4.48 billion by the last quarter of 2025. The steady increase, with some minor fluctuations, indicates expanding short-term financial obligations, possibly linked to the growth in accrued expenses and other current liabilities.
Long-Term Operating Lease Liabilities
Data on long-term operating lease liabilities begins only in late 2020, initially reported at about 350 million. These liabilities remained relatively stable around the 350 to 380 million range until early 2024, after which there was a sharp increase to over 1.5 billion in 2024, maintaining at high levels through mid-2025 and then increasing again towards nearly 1.83 billion by the end of the period. This shift indicates a significant rise in lease obligations, potentially due to new operating leases or changes in lease accounting.
Other Long-Term Liabilities
Other long-term liabilities started at approximately 893 million and showed some variation but generally maintained a level between 700 million and 1.2 billion. There was a noticeable increase in late 2022 and early 2023, followed by a mild decline and then a gradual increase towards mid-2025, suggesting moderate variability in long-term obligations outside operating leases.
Long-Term Liabilities
Overall long-term liabilities showed growth, from about 893 million in early 2020 to over 3 billion by the final quarter of 2025. The notable spike beginning in late 2022 corresponds with increases in lease and other long-term liabilities. The upward trend demonstrates an expansion in long-term financial commitments.
Total Liabilities
Total liabilities increased steadily from approximately 2.43 billion to 7.54 billion over the course of the reported quarters. This considerable rise reflects both the growth in current liabilities and the significant expansion in long-term liabilities, indicating a heavier overall indebtedness profile.
Common Stock and Additional Paid-in Capital
Common stock par value remained stable at about 2.6 million shares, with minor fluctuations geared towards maintaining share count. Additional paid-in capital showed a declining trend overall, shrinking from around 7.7 billion early on to 5.0 billion by the last quarter. The decreases may be indicative of share repurchases, amortization of equity components, or other capital structure adjustments.
Accumulated Other Comprehensive Income (Loss)
This component displayed variability, oscillating between gains and losses. Initially positive in 2020, it dipped into negative territory through 2021, reverted to positive during 2022, and again turned negative in late 2023. The fluctuations suggest exposure to market valuation changes or currency translation differences affecting comprehensive income.
Retained Earnings (Accumulated Deficit)
Retained earnings moved from a substantial deficit position (-1.25 billion) into positive territory by late 2020 and continued increasing to reach over 12.3 billion by late 2025. Although a decrease was observed in early to mid-2024, the overall upward trajectory reflects sustained profitability and accumulation of earnings retained within the company.
Shareholders' Equity
Shareholders' equity exhibited consistent growth, expanding from approximately 6.46 billion in early 2020 to over 17.3 billion by the end of the reporting period. Despite a dip in 2024 corresponding to a decline in retained earnings and other comprehensive income, equity strength appears robust, supported by increases in retained earnings and additional paid-in capital (despite its downward trend).
Total Liabilities and Shareholders’ Equity
The combined total of liabilities and shareholders’ equity steadily increased from roughly 8.9 billion in early 2020 to nearly 24.9 billion by late 2025. This reflects overall growth in the company's financial size and capital structure, driven by expansion in liabilities more heavily than shareholders' equity in the later periods.